The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers

Gynecologic Cancer Clinical Trial

Official title:

The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers:Avon Program for Meditation and Healing

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00248911
• Other study ID #: 0209005792
• Status: Completed
• Phase: N/A
• First received: November 3, 2005
• Last updated: February 17, 2017
• Start date: May 2003
• Est. completion date: March 2010

Study information

• Verified date: February 2017
• Source: Weill Medical College of Cornell University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Women with breast cancer and other gynecologic cancers often suffer significant distress and disability from their disease. A practice of meditation-based stress reduction and cognitive-affective-behavioral learning may help women with these conditions decrease their suffering and improve their quality of life.

Description:

The objective of this project in women recently treated for breast or other gynecologic cancer is to determine whether an intervention program consisting of group and individual instruction in a meditation-based practice of stress-reduction and cognitive-affective-behavioral learning has the potential for reducing disabling distress and improving quality of life in a population vulnerable to the progression or recurrence of disease. Quality of life will be assessed at 12 months.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 94
• Est. completion date: March 2010
• Est. primary completion date: March 2010
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 101 Years

Eligibility

Inclusion Criteria:

• All women with stage I-III breast or other gynecologic cancer who have received treatment within the preceding year will be eligible for inclusion in the study.

Exclusion Criteria:

• Patients who refuse to participate will be excluded

• Patients with Metastatic cancer are excluded.

Related Conditions & MeSH terms

• Breast Cancers
• Breast Neoplasms
• Gynecologic Cancer

Intervention

Behavioral:
• Mindfulness based meditation program
Subjects will participate in an intervention consisting of group and individual instruction in a meditation-based practice of stress-reduction and cognitive-affective-behavioral learning.

Locations

Country	Name	City	State
United States	Weill Cornell Medical College-New York Hospital	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Weill Medical College of Cornell University	Avon Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life will be assessed by within patient differences in the FACT-G (General Functional Assessment of Cancer Treatment Scale), as well as with the disease specific subscales at baseline and at 12 months.		Subjects will complete questionnaires at baseline and closeout. Patients will participate in the meditation program weekly for 20 weeks.